Skip to content

Clinical trials

Completed Lung Diseases, Obstructive trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Obstructive Status: Completed Country / region: United States Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20055
20071
20093
20101
20111
20123
20132
20147
20154
20166
20172
20181
20201
20211
20222
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca17
University of Michigan5
Columbia University2
Mayo Clinic2
National Heart, Lung, and Blood Institute (NHLBI)2
Novartis Pharmaceuticals2
University of Chicago2
Albert Einstein College of Medicine1
Brigham and Women's Hospital1
DARTNet Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Obstructive50
Lung Diseases30
Respiratory Tract Diseases25
Asthma24
Pulmonary Disease, Chronic Obstructive22
Bronchial Diseases21
Immune System Diseases6
Hypersensitivity5
Respiratory Hypersensitivity5
Hypersensitivity, Immediate4

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.